Cabozantinib,Nivolumab,Ipilimumab
bms
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'rcc,(-irccs),(-srcc),(-urcc)', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
happy to participate on #opticrcc first prospectively molecularly selected trial in #kidneycancer! in midst of opening. spearheaded by team #gu23 
I treat & research GU cancers @UTSW Dallas. Columbia/Harvard Med/Duke alum; Mom & wife Tweets=my opinions ASCO: https://t.co/Whk29PATXe